Amy E Mckee - Net Worth and Insider Trading

Amy E Mckee Net Worth

The estimated net worth of Amy E Mckee is at least $309,395 dollars as of 2026-06-26. Amy E Mckee is the Director of BioCryst Pharmaceuticals Inc and owns about 31,252 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $309,395. Details can be seen in Amy E Mckee's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Amy E Mckee has not made any transactions after 2026-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Amy E Mckee

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Amy E Mckee Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy E Mckee owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of Amy E Mckee’s form 4 insider trades.

Insider Ownership Summary of Amy E Mckee

Ticker Company Transaction Date Type of Owner
BCRX BioCryst Pharmaceuticals Inc 2026-05-18 director

Amy E Mckee Latest Holdings Summary

Amy E Mckee currently owns a total of 1 stock. Amy E Mckee owns 31,252 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 18, 2026, with a value of $309,395.

Latest Holdings of Amy E Mckee

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2026-05-18 31,252 9.90 309,395

Holding Weightings of Amy E Mckee


Amy E Mckee Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy E Mckee has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 11,180 shares on May 18, 2026, which brought Amy E Mckee around $100,285.

Insider Trading History of Amy E Mckee

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy E Mckee Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Amy E Mckee owns.
View BCRX Analysis

Amy E Mckee Ownership Network

Ownership Network List of Amy E Mckee

No Data

Ownership Network Relation of Amy E Mckee

Insider Network Chart


Amy E Mckee Owned Company Details

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

Amy E Mckee is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Legal Officer Alane P Barnes , Chief R&D Officer Sandeep Menon , and Chief Commercial Officer Ronald Dullinger .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, Amy E Mckee made 1 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net sale of 11,180. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 417,163 shares made by Alane P Barnes , a net sale of 119,933 shares made by Theresa Heggie , and a net sale of 9,600 shares made by Machelle Sanders .

In summary, during the past 3 months, insiders sold 73,680 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 73,680 shares. During the past 18 months, 557,876 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 557,876 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

Amy E Mckee Mailing Address

Above is the net worth, insider trading, and ownership report for Amy E Mckee. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Amy E Mckee's mailing address is: Durham Nc 27703.